A new computational drug repurposing method using established disease–drug pair knowledge
Open Access
- 6 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (19) , 3672-3678
Abstract
Drug repurposing is a potential alternative to the classical drug discovery pipeline. Repurposing involves finding novel indications for already approved drugs. In this work, we present a novel machine learning-based method for drug repurposing. This method explores the anti-similarity between drugs and a disease to uncover new uses for the drugs. More specifically, our proposed method takes into account three sources of information: (i) large-scale gene expression profiles corresponding to human cell lines treated with small molecules, (ii) gene expression profile of a human disease and (iii) the known relationship between Food and Drug Administration (FDA)-approved drugs and diseases. Using these data, our proposed method learns a similarity metric through a supervised machine learning-based algorithm such that a disease and its associated FDA-approved drugs have smaller distance than the other disease-drug pairs. We validated our framework by showing that the proposed method incorporating distance metric learning technique can retrieve FDA-approved drugs for their approved indications. Once validated, we used our approach to identify a few strong candidates for repurposing. The R scripts are available on demand from the authors. Supplementary data are available at Bioinformatics online.Keywords
Funding Information
- NIH (R01 DK089167)
- NSF (213 DBI-0965741, R42 GM087013)
- Robert J. Sokol Endowment in Systems Biology
This publication has 62 references indexed in Scilit:
- Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activationCell Death & Disease, 2013
- Drug–target interaction prediction through domain-tuned network-based inferenceBioinformatics, 2013
- Transcriptional data: a new gateway to drug repositioning?Drug Discovery Today, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Exploiting drug-disease relationships for computational drug repositioningBriefings in Bioinformatics, 2011
- The antitumor activity of the fungicide ciclopiroxInternational Journal of Cancer, 2010
- Predicting new molecular targets for known drugsNature, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003